"Vitreoretinal Consultants of NY is the premier destination for retinal care in Long Island and Queens, New York. Visit our Riverhead, NY center to get top retina specialist care for macular degeneration (AMD), diabetic retinopathy, retinal tears & detachments, macular conditions, and more. Our retinal care services include diagnostic testing such as fluorescein angiography, as well as treatments such as eye injections (Avastin, Lucentis, Eylea), vitrectomy, and scleral buckle. Our retina research center also participates in many clinical trials. Our Riverhead, NY location is easily accessible to patients from the North and South forks of Suffolk County, including East Hampton, Southampton, Shelter Island, Southold, Tuckahoe, and beyond."

During the past decade, Long Island Vitreoretinal Consultants conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Long Island Vitreoretinal Consultants" #1 collaborator was "National Eye Institute (NEI)" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Long Island Vitreoretinal Consultants" are "Age Related Macular Degeneration" (1 trials), "Central Retinal Vein Occlusion" (1 trials) and "Macular Edema" (1 trials). Many other conditions were trialed in "Long Island Vitreoretinal Consultants" in a lesser frequency.

Most popular intervention types in "Long Island Vitreoretinal Consultants" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Avastin" (1 trials), "Ozurdex" (1 trials), "bevacizumab" (1 trials) and "ranibizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Long Island Vitreoretinal Consultants" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Long Island Vitreoretinal Consultants". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Long Island Vitreoretinal Consultants, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Long Island Vitreoretinal Consultants, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".